TRANSLATE

Welcome to Our Parkinson's Place


I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's
diseases as well and thought it would be nice to have a place where
updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please no advertisers. This is a free site for all.
Thank you.


Friday, May 5, 2017

Michael J. Fox Foundation Awards 3 Trial Centers $125,000 in New Parkinson’s Trial Recruitment Program

MAY 4, 2017   BY CAROLINA HENRIQUES IN NEWS.



The Michael J. Fox Foundation for Parkinson’s Research (MJFF) is giving three clinical trial centers a $125,000 incentive to increase accessibility and volunteer enrollment in Parkinson’s disease (PD) studies as part of its new Parkinson’s Disease Trial Recruitment Innovation (PD-TRI) program.
The centers – Barrow Neurological Institute in Phoenix, Arizona; Beth Israel Deaconess Medical Center in Boston, Massachusetts; and Oregon Health and Science University in Portland, Oregon – were selected due to their comprehensive clinical research portfolio, strong infrastructure for executing Parkinson’s trials, and commitment to provide innovative solutions for recruiting research volunteers.
Clinical trials are essential to finding new and better treatments for Parkinson’s disease. Having volunteer participants is fundamental to completing trials successfully and to develop new therapies; however, finding participants is challenging and often leads to increased costs and even to studies being abandoned.
Not knowing about research opportunities, having negative perceptions of the trial process, and having poor choices of transportation have been shown to be significant barriers to bringing eligible individuals to clinical trials.
The PD-TRI program hopes to improve the recruitment of volunteers and consequently advance research by rewarding centers working to overcome these challenges.
As part of the PD-TRI program, each center will address the above-mentioned main barriers to trial participation by promoting:
  • The creation of a clinical trial referral network of local practitioners;
  • The use of behavioral economics principles to build bridges between volunteer awareness and trial opportunities;
  • The engagement of caregivers to make trials more accessible to patients with Parkinson’s cognitive impairment;
  • Free transportation to and from study sites in partnership with Lyft Concierge, a transportation service that works to meet the needs of an aging population.
Each trial center will evaluate the impact of their selected interventions by performing ongoing qualitative and quantitative assessments. The sites will submit their experiences to peer-reviewed journals to inform trial recruitment practices elsewhere and accelerate Parkinson’s research.
“Clinical trial sites enroll, on average, only one volunteer per month,” Sohini Chowdhury, MJFF’s deputy CEO, said in a press release. “This contributes to the lengthy process of Parkinson’s drug development, and PD-TRI aims to advance understanding of recruitment to address this challenge.”
Last year, the American Parkinson Disease Association (APDA) launched a series of in-person educational seminars titled “Parkinson’s Disease: Spotlight on Clinical Trials — What You Need to Know” to spread vital information about PD trials across the United Sates.
The program was designed to provide an expert perspective on the importance of clinical trials for the advancement of Parkinson’s research and to help those affected by the disease better understand what clinical trials are, why they are so important, and the different ways one can become a trial participant.
A summary of the information discussed in these seminars, with information on how to find and participate in a clinical trial is available:
https://www.apdaparkinson.org/webinar/spotlight-parkinsons-clinical-trials/
https://parkinsonsnewstoday.com/2017/05/04/michael-j-fox-foundation-awards-3-trial-centers-125000-parkinsons-trial-recruitment-program/

No comments:

Post a Comment